Mount Vernon Cancer Centre at Mount Vernon Hospital
Northwood, England, United Kingdom
Cancer treatment center in Northwood, England
White Hill, Northwood HA6 2RN
About Mount Vernon Cancer Centre at Mount Vernon Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Mount Vernon Cancer Centre at Mount Vernon Hospital
During the past decade, Mount Vernon Cancer Centre at Mount Vernon Hospital conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 20 clinical trials were completed, i.e. on
average, 42.6% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 17 clinical trials were completed. i.e. 130.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
2006-04-24
2021-09-01
Completed
1,943
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
2007-11-02
Active, not recruiting
4,994
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
2008-05-15
Active, not recruiting
394
Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer
2008-07-30
2019-10-15
Completed
64
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
2008-06-15
2015-05-28
Completed
210
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Mount Vernon Cancer Centre at Mount Vernon Hospital" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "University College, London" with 9 trials
sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 8 trials sponsored, "Medical Research Council" with 8 trials sponsored and "Cancer Research UK"
with 8 trials sponsored. Other sponsors include 75 different institutions and
companies that sponsored additional 64 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Vernon Cancer Centre at Mount Vernon Hospital"
#1 collaborator was "Cancer Research UK" with 8 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Hoffmann-La Roche" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials as a collaborator. Other collaborators include 62 different institutions and companies that were
collaborators in the rest 63 trials.
Clinical Trials Conditions at Mount Vernon Cancer Centre at Mount Vernon Hospital
According to Clinical.Site data, the most researched conditions in "Mount Vernon Cancer Centre at Mount Vernon Hospital" are
"Ovarian Cancer" (15 trials), "Breast Cancer" (12 trials), "Fallopian Tube Cancer" (11 trials), "Lymphoma" (10 trials) and "Colorectal Cancer" (7 trials). Many other conditions were trialed in "Mount Vernon Cancer Centre at Mount Vernon Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Mount Vernon Cancer Centre at Mount Vernon Hospital
Most popular intervention types in "Mount Vernon Cancer Centre at Mount Vernon Hospital" are "Drug" (89 trials), "Radiation" (24 trials), "Biological" (23 trials), "Other" (19 trials) and "Procedure" (13 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (16 trials), "Paclitaxel" (12 trials), "radiation therapy" (12 trials), "Docetaxel" (7 trials) and "cisplatin" (7 trials). Other intervention names were less common.
Clinical Trials Genders at Mount Vernon Cancer Centre at Mount Vernon Hospital
The vast majority of trials in "Mount Vernon Cancer Centre at Mount Vernon Hospital" are
87 trials for "All" genders, 27 trials for "Female" genders and 9 trials for "Male" genders.
Clinical Trials Status at Mount Vernon Cancer Centre at Mount Vernon Hospital
Currently, there are NaN active trials in "Mount Vernon Cancer Centre at Mount Vernon Hospital".
1 are not yet recruiting,
17 are recruiting,
20 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 57 completed trials in Mount Vernon Cancer Centre at Mount Vernon Hospital,
undefined suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Mount Vernon Cancer Centre at Mount Vernon Hospital, 6 "Phase 1"
clinical trials were conducted, 36 "Phase 2" clinical
trials and 69 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 6 trials that are defined as “Not Applicable".